Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation

Abstract Background Repeat transarterial chemoembolisation (rTACE) is often required for hepatocellular carcinoma (HCC) to achieve disease control, however, current practice guidelines regarding treatment allocation vary significantly. This study aims to identify key factors associated with patient...

Full description

Bibliographic Details
Main Authors: Gauri Mishra, Anouk Dev, Eldho Paul, Wa Cheung, Jim Koukounaras, Ashu Jhamb, Ben Marginson, Beng Ghee Lim, Paul Simkin, Adina Borsaru, James Burnes, Mark Goodwin, Vivek Ramachandra, Manfred Spanger, John Lubel, Paul Gow, Siddharth Sood, Alexander Thompson, Marno Ryan, Amanda Nicoll, Sally Bell, Ammar Majeed, William Kemp, Stuart K. Roberts, The Melbourne Liver Group
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Repeat transarterial chemoembolisation
Prognosis
Alpha-fetoprotein
Online Access:http://link.springer.com/article/10.1186/s12885-020-06806-4

Internet

http://link.springer.com/article/10.1186/s12885-020-06806-4

Similar Items